AcquisitionAI
iBio, Inc. acquired RubrYc Therapeutics’ AI Drug Discovery Platform
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
iBio, Inc. -> RubrYc Therapeutics’ AI Drug Discovery Platform · $1 million
The acquired assets include: ● AI Drug Discovery Platform : A patented system that uses artificial intelligence (“AI”) to design 3D models of epitopes to facilitate the creation of better antibody drug candidates.
Open source record (SEC) ↗